Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $169.2 million.

  • Dexcom's Accumulated Expenses rose 5107.14% to $169.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $169.2 million, marking a year-over-year increase of 5107.14%. This contributed to the annual value of $169.2 million for FY2025, which is 5107.14% up from last year.
  • Dexcom's Accumulated Expenses amounted to $169.2 million in Q4 2025, which was up 5107.14% from $170.2 million recorded in Q3 2025.
  • Dexcom's 5-year Accumulated Expenses high stood at $171.0 million for Q4 2023, and its period low was $81.4 million during Q1 2021.
  • In the last 5 years, Dexcom's Accumulated Expenses had a median value of $112.4 million in 2022 and averaged $119.8 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first crashed by 3450.29% in 2024, then surged by 6086.96% in 2025.
  • Quarter analysis of 5 years shows Dexcom's Accumulated Expenses stood at $125.2 million in 2021, then increased by 7.27% to $134.3 million in 2022, then grew by 27.33% to $171.0 million in 2023, then crashed by 34.5% to $112.0 million in 2024, then soared by 51.07% to $169.2 million in 2025.
  • Its Accumulated Expenses was $169.2 million in Q4 2025, compared to $170.2 million in Q3 2025 and $129.3 million in Q2 2025.